VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs GE HealthCare Technologies Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisGE HealthCare Technologies Inc.
GEHC · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into GE HealthCare Technologies Inc.'s moat claims, evidence, and risks.
View GEHC analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 63 / 100 for GE HealthCare Technologies Inc.).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); GE HealthCare Technologies Inc. has 4 segments (45% in Imaging).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; GE HealthCare Technologies Inc. has 8 across 4.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
GE HealthCare Technologies Inc.
Imaging
Diagnostic imaging equipment and related service (CT, MR, molecular imaging, X-ray, women's health) and imaging IT
Global
Hospitals, imaging centers
OEM + service + software
45%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
AstraZeneca PLC strengths
GE HealthCare Technologies Inc. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
GE HealthCare Technologies Inc. segments
Full profile >Imaging
Oligopoly
Advanced Visualization Solutions (AVS)
Oligopoly
Patient Care Solutions (PCS)
Oligopoly
Pharmaceutical Diagnostics (PDx)
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.